Literature DB >> 8903245

Armed with epidemiologic research, China launches programs to prevent liver cancer.

A A Skolnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8903245

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  Immunomodulation in hepatocellular cancer.

Authors:  Sunyoung Lee; Matthew Loecher; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2018-02

3.  Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma.

Authors:  Lantu Gou; Wei Wang; Aiping Tong; Yuqin Yao; Yan Zhou; Cheng Yi; Jinliang Yang
Journal:  J Mol Med (Berl)       Date:  2011-04-08       Impact factor: 4.599

4.  Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.

Authors:  Chang Liu; Li-gen Duan; Wu-sheng Lu; Lu-nan Yan; Guang-qin Xiao; Li Jiang; Jian Yang; Jia-yin Yang
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

5.  Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.

Authors:  Tingting Li; Mengjiao Lv; Xiaohua Chen; Yongsheng Yu; Guoqing Zang; Zhenghao Tang
Journal:  Drug Des Devel Ther       Date:  2019-04-23       Impact factor: 4.162

6.  Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.

Authors:  Mark op den Winkel; Dorothea Nagel; Julia Sappl; Philip op den Winkel; Rolf Lamerz; Christoph J Zech; Gundula Straub; Thomas Nickel; Markus Rentsch; Petra Stieber; Burkhard Göke; Frank T Kolligs
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

7.  Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials.

Authors:  Takafumi Koyama; Shunsuke Kondo; Toshio Shimizu; Yutaka Fujiwara; Chigusa Morizane; Yasunari Sakamoto; Takuji Okusaka; Noboru Yamamoto
Journal:  Front Oncol       Date:  2019-04-18       Impact factor: 6.244

8.  A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia.

Authors:  Jiong Yu; Xiaowei Shi; Chunzhang Yang; Petra Bullova; Christopher S Hong; Cody L Nesvick; Pauline Dmitriev; Karel Pacak; Zhengping Zhuang; Hongcui Cao; Lanjuan Li
Journal:  Aging (Albany NY)       Date:  2020-04-01       Impact factor: 5.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.